Amass was founded by Alexander Junge, Henrik Jensen in 2022.

Who are Amass's investors?

Amass's investors include Novo Holdings, Giant Ventures Global Llp, Kost Capital.

Amass

Founded 2022 · 9 employees on LinkedIn · 3 known investors

Amass operates an agentic data platform that unifies over 500 million scientific documents — including research literature, patents, clinical trials, regulatory filings, and web sources — into a single engine that returns answers cited to their source. It serves researchers, life science companies, and research institutions through an app, API, and MCP interface, with each claim traceable to underlying evidence.

AI & Machine Learning Biotech Data & Infrastructure

Founders & leadership

Amass was founded in 2022 by Alexander Junge and Henrik Jensen.

Alexander JungeinCo-Founder & CTO

Henrik JenseninCo-Founder & CEO

Investors · 3

Novo Holdings✓ verifiedCopenhagen · $1.1M – $54M

Giant Ventures Global LlpLondon · $2M – $20M

Kost CapitalFrederiksberg

Competitors · 1

by search overlap

Omass4 shared keywordsOMass uses native mass spectrometry, proprietary biochemistry and custom chemistry to study drug targets and their interactions with their native biological environment outside the confounding complexity of the cell. It operates in drug discovery within the biotech/pharmaceutical sector.

Companies competing with Amass for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Amass Brands raises SAFE to $1,735,000 | AMSS 8-K Filingstocktitan.net · Jun 2026

Amass' CEO has raised millions for his alcohol startups, but now he's crowdfunding part of his next round after seeing the value of fans-turned-investorsbusinessinsider.com · May 2021

Frequently asked questions

What does Amass do?: Amass operates an agentic data platform that unifies over 500 million scientific documents — including research literature, patents, clinical trials, regulatory filings, and web sources — into a single engine that returns answers cited to their source. It serves researchers, life science companies, and research institutions through an app, API, and MCP interface, with each claim traceable to underlying evidence.
Who founded Amass?: Amass was founded by Alexander Junge, Henrik Jensen in 2022.
Who are Amass's investors?: Amass's investors include Novo Holdings, Giant Ventures Global Llp, Kost Capital.